InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Doyle Mittie. Director active across 1 company, notably Avalo Therapeutics, Inc.. Cumulatively, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €9k. History available since 21 May 2026. The latest transaction was disclosed on 28 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations